India may have to wait longer for Pfizer, GSK's Covid drugs

Last month Pfizer had announced an agreement with the UN's Medicines Patent Pool (MPP) for licensing antiviral intellectual property to MPP with the goal of making the drug available in low and middle-income countries.

via Economictimes